As pediatric dietitians working in infant feeding, many of us are familiar with the landmark LEAP and PETIT food allergy prevention trials. These studies led to a shift in early allergen introduction from a controversial idea to a cornerstone of food allergy prevention. And it meant rethinking how we guided families, especially those with infants at higher risk.
A Refresher on the Landmark Trials
The LEAP Trial (Peanut) – 2015
- The LEAP (Learning Early About Peanut Allergy) trial first demonstrated that early, regular peanut intake could dramatically reduce peanut allergy.
- High-risk infants who consumed peanut from infancy to age 5 showed an approximate 80% lower risk of peanut allergy than those who avoided peanuts. This study fundamentally shifted prevention guidelines around the world.
The PETIT Trial (Egg) – 2017
- Infants with eczema were randomized to receive heated egg powder starting at 6 months (after a 2-step introduction), or placebo.
- By 12 months, egg allergy occurred in 8% of the early-egg group vs. 38% of the placebo group, a nearly 80% reduction, similar to LEAP.
- Importantly, PETIT showed that heated egg, introduced gradually, is safe and effective even in higher-risk infants.
But how much has guideline-driven practice actually changed food allergy outcomes on a population level?
What the New Data Shows – Key Stats
In November 2025, a study by Gabryszewski and colleagues was published in Pediatrics showing early allergen introduction guidelines are associated with meaningful reductions in food allergy diagnoses by age 3.
They looked at allergy diagnoses in infants before and after early-introduction guidelines became common in pediatric practice. The researchers used electronic health records from pediatric clinics across the U.S., comparing thousands of children.
Here’s the essential take-home:
- Peanut allergy dropped from ~0.79% to ~0.45% after guidelines were implemented, about a 43% decrease.
- Overall IgE-mediated food allergy fell from 1.46% to 0.93%, a 36% decrease.
- Peanut allergy used to be the most common diagnosed food allergy. Now, egg allergy is more common than peanut in post-guideline cohorts.
This shift shows real-world progress: early introduction recommendations aren’t just theoretical; they are changing allergy patterns across pediatric populations.
Why It Matters for Dietitians
Clinical trials like LEAP and PETIT are powerful, but they take place in highly controlled settings. This new evidence demonstrates that recommendation uptake in everyday pediatric practice correlates with lower allergy risk, which is reassuring for dietitians counseling families outside of research contexts.
Counseling Take-Home Points: Integrating the Evidence
- Emphasize early (but safe) introduction: Introduce peanut and egg as early as ~4–6 months, once the infant is developmentally ready.
- Promote consistent exposure: After initial introduction, aim for regular ingestion (e.g., a few times per week) to maintain tolerance.
- Normalize the benefits: Use the real-world data (43% drop in peanut allergy, 36% overall drop in IgE-mediated food allergies) to reassure parents that this isn’t just “ideal,” but beneficial at a population level.
Looking Ahead
The Gabryszewski study gives hope: early-allergen introduction is not just a research concept, it appears to be working at the population level. But there’s still more to learn. Questions remain about the optimal amount, duration, and frequency of feeding various allergens, especially beyond peanut and egg.
As dietitians, we can stay informed, adapt as evidence evolves, and lead in helping families implement strategies that truly work.
What’s New at Nutrition Masterclass?
- Our Black Friday Sale will be happening for one day only – November 28, 2025
- Keep an eye on your inbox this week for coupon codes for 25 – 50% off everything
Charlene & Julie
Co-Founders, Nutrition Masterclass
P.S. Our Black Friday deals are just around the corner! Check your inbox later this week to get your CPEUs at the lowest price of the year.